Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

Not Applicable

Completed

Conditions: Weight Loss
NAFLD
Liver Diseases

Interventions: Behavioral: YMCA class

First Posted Date: 2018-04-30

Last Posted Date: 2023-02-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 48

Registration Number: NCT03512184

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

Not Applicable

Terminated

Conditions: Newly Diagnosed Breast Cancer

Interventions: Diagnostic Test: Hybrid breast FDG PET/MRI

First Posted Date: 2018-04-27

Last Posted Date: 2023-02-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 14

Registration Number: NCT03510988

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Ablative Therapy in the Management of Prostate Cancer

Recruiting

Conditions: Prostate Cancer

Interventions: Device: cryotherapy

First Posted Date: 2018-04-10

Last Posted Date: 2024-02-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT03492424

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions

Not Applicable

Completed

Conditions: Pain, Chronic
Negative Emotions

Interventions: Behavioral: Path Pain

First Posted Date: 2018-04-04

Last Posted Date: 2024-12-18

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 157

Registration Number: NCT03487822

Locations: 🇺🇸
Center on Aging (formerly Wright Center on Aging), New York, New York, United States

Trial of an Intervention to Improve Metformin Persistence and Adherence

Phase 4

Completed

Conditions: Tolerance
Metformin Adverse Reaction

Interventions: Drug: Placebo oral capsule
Drug: Metformin Extended Release Oral Tablet

First Posted Date: 2018-03-16

Last Posted Date: 2020-12-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 13

Registration Number: NCT03467763

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

Phase 1

Recruiting

Conditions: Brain Metastases
Metastatic Breast Cancer

Interventions: Drug: Pembrolizumab

First Posted Date: 2018-02-28

Last Posted Date: 2024-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 41

Registration Number: NCT03449238

Locations: 🇺🇸
Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York Presbyterian Hospital - Queens, New York, New York, United States

Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: PET/CT with Gallium-68 labeled PSMA-HBED-CC
Drug: Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC
Drug: PET/MRI with Gallium-68 labeled PSMA-HBED-CC

First Posted Date: 2018-02-20

Last Posted Date: 2023-03-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 273

Registration Number: NCT03439033

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Parent Video Feedback Intervention Study

Not Applicable

Completed

Conditions: Autism Spectrum Disorder
Parent-Child Relations

Interventions: Behavioral: Control Group
Behavioral: Treatment Condition

First Posted Date: 2018-01-12

Last Posted Date: 2021-10-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT03397719

Locations: 🇺🇸
Weill Cornell Medicine Center for Autism and the Developing Brain, White Plains, New York, United States

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Phase 1

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Leukemia, Relapsed Adult Acute Myeloid
Myelodysplastic Syndromes, Previously Treated

Interventions: Drug: CPX-351
Drug: Fludarabine
Drug: Melphalan
Drug: Rabbit Anti-Human T-Lymphocyte Globulin
Biological: Haplo-Cord Stem Cell Transplantation

First Posted Date: 2018-01-08

Last Posted Date: 2022-12-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 14

Registration Number: NCT03393611

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome

Completed

Conditions: Prostate Cancer
Breast Cancer

First Posted Date: 2017-12-26

Last Posted Date: 2022-08-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 66

Registration Number: NCT03383107

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy